Speaker illustration

Professor David Moliterno

University of Kentucky, Lexington (United States of America)

Member of:

European Society of Cardiology
EAPCI

David J. Moliterno, MD (FESC, FACC, FSCAI, FAHA) is a Professor at the University of Kentucky. He was an attending cardiologist at the Cleveland Clinic for 10 years before joining the University of Kentucky, where he was chief of cardiovascular medicine and subsequently chair of internal medicine. Dr. Moliterno has been a visiting professor or lecturer in more than 30 countries. He is the author of over 400 publications and editor of 8 textbooks. He has been the primary author of publications in BMJ, Circulation, EHJ, JACC, JAMA, Lancet, and NEJM. He is currently the Editor-in-Chief for the JACC: Cardiovascular Interventions and serves on the advisory board of the US FDA. As a clinical researcher, Dr. Moliterno has been a leader in numerous multinational investigational studies. Collectively, these studies have involved over $1 billion in clinical trial research. His primary interests involve acute coronary syndromes, antithrombotic therapies, and interventional cardiology.

Translational research in acute coronary syndrome registries

Event: ESC CONGRESS 2019

Topic: Treatment

Session type: Rapid Fire Abstracts

Thumbnail

Alternative treatments for myocardial ischaemia?

Event: ESC CONGRESS 2017

Topic: Ischaemia, experimental studies

Session type: Moderated Posters

Thumbnail

This platform is supported by

logo Novo Nordisk